StevenBDeitelzweigMDphysician
Internal Medicine • Jefferson, LAHospital Medicine/Hospitalist, Vascular Medicine
regional VPMA system chairman - hospital medicine
Dr. Deitelzweig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
Jefferson, LA 70121Phone+1 866-624-7637
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1989 - 1992
Stony Brook University Health Sciences Center School of MedicineClass of 1989
Certifications & Licensure
LA State Medical License 1992 - Present
FL State Medical License 1994 - 2025
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation Who Switched from Warfarin to Direct Oral Anticoagulants in Medicare Population.Nipun Atreja, Anandkumar Dubey, Amiee Kang, Jenny Jiang, Melissa Hagan
Advances in Therapy. 2025-01-30 - 1 citationsEffectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims.Gregory Y H Lip, Virginia Noxon, Amiee Kang, Xuemei Luo, Nipun Atreja
Journal of Thrombosis and Thrombolysis. 2024-08-01 - 1 citationsClinical Impact of Switching or Continuation of Apixaban or Rivaroxaban among Patients with Non-Valvular Atrial Fibrillation.Steven Deitelzweig, Amiee Kang, Jenny Jiang, Chuan Gao, Xuemei Luo
Journal of Clinical Medicine. 2024-02-14
Abstracts/Posters
- [Board 280] Comparison of Major Bleeding and Stroke-Related Hospital Readmissions Among Hospitalized Nonvalvular Atrial Fibrillation Patients Treated With Warfarin and...Steven Deitelzweig, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- Differences in Admission Rates Among Patients Treated with Apixaban Vs. Warfarin for Venous Thromboembolism in the Emergency Department61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Frail Nonvalvular Atrial Fibrillation Patients2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Press Mentions
Apixaban Has Edge over Other NOACs in Large, Real-World AnalysisMarch 12th, 2018
Findings Released from Largest Real-World Data Analysis of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral AnticoagulantsMarch 11th, 2018
Professional Memberships
- Senior Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
